Replies to post #2734 on Axim Biotechnologies Inc (AXIM)

[Devolution]

That rollout was supposed to happen in Q1 2022. According to my watch it is Q1 2022. CRICKETS!!!

The rollout begins in the 1st quarter of 2022. Don't expect to hear anything about it in a Press Release. Companies do not Press Release every time they sell something. It is just not done.

HOWEVER, you will see the beginning of revenue accumulation on the 1st quarter 10-K, due out on May 15th. THAT is when you will see/hear something about the DED test kits, but it is just the start, so don't expect revenues at first to be jaw-dropping.

CLEARLY, Empowered Diagnostics is NOT the manufacturer of the DED test kits (otherwise, we would see them in their product line). Empowered's specialty is low cost, mass production - hence the reason why AXIM handed over EVERYTHING to them (from the "sauce" to dealing with the FDA in obtaining the EUA) in regards to IMMUNOPASS, in exchange for royalties of 8% of gross sales. The DED line, though potentially highly profitable, is NOT something that needs to be mass produced. An antibody test kit designed to show one's levels of antibodies against COVID-19 has a market size limited only by the world's population (currently 7.8 billion). The market for Dry Eye Disease is substantially much smaller. Rest assured, DED test kits are being manufactured and sold, but not through Empowered. Undoubtedly, AXIM has made a (similar) deal with another manufacturer an the roll out of the DED line has begun (1st Quarter 2022).

IF and WHEN the FDA grants an EUA for Immunopass THAT event will certainly be Press Released by AXIM, not because AXIM is talking about selling something, but rather because AXIM has an SEC obligation to inform their shareholders of events that will dramatically effect the company.

Keep in mind the FDA put out a news release on 11/15/21 stating that their focus would turn to at home test kits (of which there currently are MANY to detect the presence of the virus but NONE to detect Neutralizing Antibodies), and 3 days later AXIM took the out-of-the-ordinary step to Press Release that News, applauding the FDA's initiative and linking the FDA's announcement directly to AXIM's own product, Immunopass.

It is just a matter of time. There is absolutely NO DOUBT that the FDA is heavily politically controlled. AXIM just has to be patient until the politics of society catches up with replacing Viral test kits with Antibody test kits, and Vaccine Passports with Antibody Passports.

Fortunately, every day, society moves one step closer to that time period.

Just last week, the Supreme Court shot down Biden's Vaccine Mandate (the one requiring companies nationwide with 100 or more employees to have 100 % employee vaccination compliance or face stiff penalties).

Patience. It is just a matter of time. Immunopass will gets its approvals, here in the USA, as well as in Canada and in the EU.

It is just a matter of time........